241 related articles for article (PubMed ID: 14984687)
1. Pediatric neurotransmitter diseases.
Pearl PL; Wallis DD; Gibson KM
Curr Neurol Neurosci Rep; 2004 Mar; 4(2):147-52. PubMed ID: 14984687
[TBL] [Abstract][Full Text] [Related]
2. The pediatric neurotransmitter disorders.
Pearl PL; Taylor JL; Trzcinski S; Sokohl A
J Child Neurol; 2007 May; 22(5):606-16. PubMed ID: 17690069
[TBL] [Abstract][Full Text] [Related]
3. Clinical Use of CSF Neurotransmitters.
Rodan LH; Gibson KM; Pearl PL
Pediatr Neurol; 2015 Oct; 53(4):277-86. PubMed ID: 26194033
[TBL] [Abstract][Full Text] [Related]
4. Inherited disorders of GABA metabolism.
Jakobs C; Jaeken J; Gibson KM
J Inherit Metab Dis; 1993; 16(4):704-15. PubMed ID: 8412016
[TBL] [Abstract][Full Text] [Related]
5. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
Ng J; Papandreou A; Heales SJ; Kurian MA
Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380
[TBL] [Abstract][Full Text] [Related]
6. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes.
Kurian MA; Gissen P; Smith M; Heales S; Clayton PT
Lancet Neurol; 2011 Aug; 10(8):721-33. PubMed ID: 21777827
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of neurotransmitter disorders.
Pearl PL; Hartka TR; Taylor J
Curr Treat Options Neurol; 2006 Nov; 8(6):441-50. PubMed ID: 17032564
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders.
Ng J; Heales SJ; Kurian MA
Paediatr Drugs; 2014 Aug; 16(4):275-91. PubMed ID: 25011953
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of the disorders of GABA metabolism in children.
Pearl PL; Gibson KM
Curr Opin Neurol; 2004 Apr; 17(2):107-13. PubMed ID: 15021235
[TBL] [Abstract][Full Text] [Related]
10. The lumbar puncture for diagnosis of pediatric neurotransmitter diseases.
Hyland K
Ann Neurol; 2003; 54 Suppl 6():S13-7. PubMed ID: 12891649
[TBL] [Abstract][Full Text] [Related]
11. GABA, gamma-hydroxybutyric acid, and neurological disease.
Wong CG; Bottiglieri T; Snead OC
Ann Neurol; 2003; 54 Suppl 6():S3-12. PubMed ID: 12891648
[TBL] [Abstract][Full Text] [Related]
12. Approaches for diagnosis and treatment in neurotransmitter disorders of childhood.
Havalı C; Dorum S; Ekici A; Görükmez Ö
Metab Brain Dis; 2021 Dec; 36(8):2255-2262. PubMed ID: 34550503
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Biogenic Monoamine Analysis for Diagnosis of Primary Neurotransmitter Disorders.
Lokhande RV; Dherai AJ; Bhagure GR; Udani VP; Kulkarni SD; Ashavaid TF
Indian J Pediatr; 2021 Dec; 88(12):1241-1243. PubMed ID: 34541626
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid investigations for neurometabolic disorders.
Hoffmann GF; Surtees RA; Wevers RA
Neuropediatrics; 1998 Apr; 29(2):59-71. PubMed ID: 9638660
[TBL] [Abstract][Full Text] [Related]
15. [Inborn errors of neurotransmitters in neuropaediatrics].
García-Cazorla A; Ormazábal A; Artuch R; Pérez-Dueñas B; López-Casas J; Fernández-Alvarez E; Campistol J
Rev Neurol; 2005 Jul 16-31; 41(2):99-108. PubMed ID: 16028189
[TBL] [Abstract][Full Text] [Related]
16. When do we need to perform a diagnostic lumbar puncture for neurometabolic diseases? Positive yield and retrospective analysis from a tertiary center.
Haliloğlu G; Vezir E; Baydar L; Onol S; Sivri S; Coşkun T; Topçu M
Turk J Pediatr; 2012; 54(1):52-8. PubMed ID: 22397043
[TBL] [Abstract][Full Text] [Related]
17. [Pediatric neurotransmitter disease in Japan].
Shintaku H
No To Hattatsu; 2012 Sep; 44(5):361-7. PubMed ID: 23012864
[TBL] [Abstract][Full Text] [Related]
18. Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders.
Cortès-Saladelafont E; Molero-Luis M; Cuadras D; Casado M; Armstrong-Morón J; Yubero D; Montoya J; Artuch R; García-Cazorla À;
Dev Med Child Neurol; 2018 Aug; 60(8):780-792. PubMed ID: 29577258
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of amino acid neurotransmitters: the synaptic disorder underlying inherited metabolic diseases.
Kölker S
J Inherit Metab Dis; 2018 Nov; 41(6):1055-1063. PubMed ID: 29869166
[TBL] [Abstract][Full Text] [Related]
20. Effects of two substituted hydrazine monoamine oxidase (MAO) inhibitors on neurotransmitter amines, gamma-aminobutyric acid, and alanine in rat brain.
Yamada N; Takahashi S; Todd KG; Baker GB; Paetsch PR
J Pharm Sci; 1993 Sep; 82(9):934-7. PubMed ID: 7901387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
